Skip to main content
. 2021 Nov 11;61(7):2826–2834. doi: 10.1093/rheumatology/keab838

Fig. 1.


Fig. 1

Anti-CarPA reactivity against specific antigens levels, receiver-operator curves, and specificity overlap

(A–E) Anti-CarPA reactivity against specific antigens levels in ERA patients (n=189) and HCs (n=44). (F–K) Receiver operator curves (ROCs) for the different anti-CarPA antibodies. The diagonal reference line indicates no discrimination between RA patients and HCs. (L) Anti-CarPA specificity overlap in ERA patients. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.